Meta-analysis of 6 RCTs (156 adults) in cutaneous sarcoidosis: pharmacological therapies did not significantly improve clinical response vs placebo (OR 2.24; 95% CI 0.73–6.90). Non-significant trend for quality of life; no difference in serious adverse events.
Meta-analysisn = 156
Thianich et al. The Efficacy of Different Treatment Options in Cutaneous Sarcoidosis: A Meta-analysis of RCTs